PTPN12 and triple-negative breast carcinoma: PTPN12 phosphatase function is compromised in breast cancer by inactivating mutations, deletions, or loss of expression, leading to the overactivation of multiple RTKs, particularly in triple-negative breast cancer (TNBC) subsets.